• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肺循环中血流动力性应激相关的肺血管疾病。

Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.

机构信息

Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Compr Physiol. 2011 Jan;1(1):123-39. doi: 10.1002/cphy.c090004.

DOI:10.1002/cphy.c090004
PMID:23737167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3730284/
Abstract

Hemodynamic stress in the pulmonary vessel is directly linked to the development of vascular remodeling and dysfunction, ultimately leading to pulmonary hypertension. Recently, some advances have been made in our molecular understanding of the exogenous upstream stimuli that initiate hemodynamic pertubations as well as the downstream vasoactive effectors that control these responses. However, much still remains unknown regarding how these complex signaling pathways connect in order to result in these characteristic pathophysiological changes. This chapter will describe our current understanding of and needed areas of research into the clinical, physiological, and molecular changes associated with pressure/volume overload in the pulmonary circulation.

摘要

肺血管中的血流动力应激与血管重构和功能障碍的发展直接相关,最终导致肺动脉高压。最近,我们在分子水平上对外源性上游刺激物的理解有了一些进展,这些刺激物引发血流动力学紊乱,下游的血管活性效应物控制这些反应。然而,对于这些复杂的信号通路如何连接以导致这些特征性的病理生理变化,我们仍然知之甚少。本章将描述我们目前对与肺循环压力/容量过载相关的临床、生理和分子变化的理解,以及需要研究的领域。

相似文献

1
Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.与肺循环中血流动力性应激相关的肺血管疾病。
Compr Physiol. 2011 Jan;1(1):123-39. doi: 10.1002/cphy.c090004.
2
[Is it necessary to define new hemodynamic indexes of pulmonary hypertension? ].[是否有必要定义肺动脉高压的新血流动力学指标?]
Rev Esp Cardiol. 2003 Nov;56(11):1041-2. doi: 10.1016/s0300-8932(03)77012-2.
3
Pulmonary Hypertension and Heart Failure: A Dangerous Liaison.肺动脉高压与心力衰竭:危险的联姻。
Heart Fail Clin. 2018 Jul;14(3):297-309. doi: 10.1016/j.hfc.2018.02.006.
4
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS.急性呼吸窘迫综合征大型动物模型中主动脉和肺动脉血流动力学的有创监测
J Vis Exp. 2018 Nov 26(141). doi: 10.3791/57405.
5
[Na K ATPase activity and pulmonary hemodynamics in the development of arterial hypertension].[钠钾ATP酶活性与动脉高血压发展过程中的肺血流动力学]
Kardiologiia. 1992 Mar;32(3):44-6.
6
Altered endothelial function in lambs with pulmonary hypertension and acute lung injury.患有肺动脉高压和急性肺损伤的羔羊的内皮功能改变。
Pediatr Pulmonol. 1999 Mar;27(3):147-56. doi: 10.1002/(sici)1099-0496(199903)27:3<147::aid-ppul1>3.0.co;2-p.
7
Unraveling the mechanism of high altitude pulmonary edema.揭示高原肺水肿的发病机制。
High Alt Med Biol. 2004 Summer;5(2):125-35. doi: 10.1089/1527029041352063.
8
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans.撒哈拉以南非洲黑人的肺血管功能与运动能力
J Appl Physiol (1985). 2015 Sep 1;119(5):502-7. doi: 10.1152/japplphysiol.00466.2015. Epub 2015 Jul 23.
9
Exercise physiology and pulmonary arterial hypertension.运动生理学与肺动脉高压。
Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):172-9. doi: 10.1016/j.pcad.2012.07.003.
10
[Central, pulmonary and cerebral hemodynamics in various stages and hemodynamic variants of hypertension].[高血压各阶段及血流动力学变异中的中心、肺和脑血流动力学]
Kardiologiia. 1990 Jul;30(7):92-3.

引用本文的文献

1
Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.在类人模型中逆转肺动脉高压:内皮二氢叶酸还原酶的治疗靶点。
Circ Res. 2024 Feb 16;134(4):351-370. doi: 10.1161/CIRCRESAHA.123.323090. Epub 2024 Feb 1.
2
Quantitative Xe MRI detects early impairment of gas-exchange in a rat model of pulmonary hypertension.定量氙气 MRI 检测肺动脉高压大鼠模型中气体交换早期受损。
Sci Rep. 2020 Apr 30;10(1):7385. doi: 10.1038/s41598-020-64361-1.

本文引用的文献

1
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.硫化氢作为一种生理性血管舒张剂:胱硫醚γ-裂解酶缺失小鼠的高血压
Science. 2008 Oct 24;322(5901):587-90. doi: 10.1126/science.1162667.
2
Pathogenic mechanisms of pulmonary arterial hypertension.肺动脉高压的发病机制
J Mol Cell Cardiol. 2008 Jan;44(1):14-30. doi: 10.1016/j.yjmcc.2007.09.006. Epub 2007 Sep 20.
3
Arterial response to shear stress critically depends on endothelial TRPV4 expression.动脉对切应力的反应取决于内皮细胞 TRPV4 的表达。
PLoS One. 2007 Sep 5;2(9):e827. doi: 10.1371/journal.pone.0000827.
4
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.西地那非可改善收缩性心力衰竭合并继发性肺动脉高压患者的运动能力和生活质量。
Circulation. 2007 Oct 2;116(14):1555-62. doi: 10.1161/CIRCULATIONAHA.107.716373. Epub 2007 Sep 4.
5
Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension.骨形态发生蛋白受体2(BMPR2)5'-非翻译区的特征及肺动脉高压中的一种新突变
Am J Respir Crit Care Med. 2007 Oct 15;176(8):819-24. doi: 10.1164/rccm.200701-164OC. Epub 2007 Jul 19.
6
Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.后基因组时代的人类疾病分类:人类病理生物学的复杂系统方法
Mol Syst Biol. 2007;3:124. doi: 10.1038/msb4100163. Epub 2007 Jul 10.
7
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells.血管内皮生长因子受体(VEGF-R)阻断导致内皮细胞凋亡、存活的CD34+前体细胞扩增并转分化为平滑肌样细胞和神经元样细胞。
FASEB J. 2007 Nov;21(13):3640-52. doi: 10.1096/fj.07-8432com. Epub 2007 Jun 13.
8
Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.活化C激酶1受体是II型骨形态发生蛋白受体的新型相互作用伙伴,可调节肺动脉高压中的平滑肌细胞增殖。
Circulation. 2007 Jun 12;115(23):2957-68. doi: 10.1161/CIRCULATIONAHA.106.670026. Epub 2007 May 21.
9
The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells.5-羟色胺转运体激活肺动脉平滑肌细胞中的血小板衍生生长因子β受体。
FASEB J. 2007 Sep;21(11):2725-34. doi: 10.1096/fj.06-8058com. Epub 2007 May 15.
10
Intravenous vasoactive intestinal polypeptide lowers pulmonary-to-systemic vascular resistance ratio in a neonatal piglet model of pulmonary arterial hypertension.静脉注射血管活性肠肽可降低新生仔猪肺动脉高压模型中的肺循环与体循环血管阻力比值。
J Pediatr Surg. 2007 May;42(5):758-64. doi: 10.1016/j.jpedsurg.2006.12.026.